Herbalife has agreed to pay a criminal penalty of more than $55 million and roughly $67 million to the U.S. Securities and Exchange Commission in a related matter, the U.S. Department of Justice announced.

A federal judge dismissed a putative class action suit after agreeing with Hi-Tech Pharmaceuticals that warning letters do not constitute final agency action.

A federal judge recently stayed a lawsuit against CV Sciences while FDA continues to look into regulating the CBD market.

If the U.S. Supreme Court agrees to review an advertising dispute between 5-hour Energy and Washington authorities, it would likely consider the doctrine of "prior substantiation," First Amendment protections offered commercial speech and...

Dietary supplement trade groups have raised concerns about a proposed rule in Oregon governing health claims in advertisements, which includes a private right of action to sue advertisers who lack "competent and reliable scientific evidence" to...

A judge granted Quincy Bioscience’s motion to decertify a class of California consumers in a 2015 lawsuit following a mistrial.

According to a Federal Trade Commission lawsuit filed in California, beginning in or around March 2020, Marc Ching of Whole Leaf Organics began marketing Thrive as an “anti viral wellness booster” that treats, prevents or reduces the risk of COVID...

A recent batch of warning letters from the Federal Trade Commission, attorney Kevin Thompson said, send a clear message that multi-level marketers should not "commingle any product promotion or income opportunity with COVID."

Some of the nation’s largest and most prominent marketers of CBD have raised various defenses in response to a wave of lawsuits filed in late 2019 against them.

CBD thrives despite unresolved or emerging legal issues, meaning companies involved with cannabinoids had better assess their current and future legal exposure.